Skip to main content
رجوع
CRON logo

Cronos Group Inc.

جودة البيانات: 100%
CRON
NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
KWD 2.58
▲ KWD 0.06 (2.38%)
القيمة السوقية: 992.32M
نطاق اليوم
KWD 2.48 KWD 2.59
نطاق 52 أسبوعًا
KWD 1.60 KWD 3.43
حجم التداول
1,490,306
متوسط 50 يوم / 200 يوم
KWD 2.61 / KWD 2.46
الإغلاق السابق
KWD 2.52

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -105.0 0.4
P/B 0.9 2.9
ROE % -0.9 3.9
Net Margin % -4.9 3.8
Rev Growth 5Y % 31.6 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 2.300 -10.9%
مكرر الربحية المستقبلي
33.6
ربحية السهم المستقبلية
KWD 0.075
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
190 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 0.150
KWD 0.149 – KWD 0.151
160 M 1
FY2028 KWD 0.140
KWD 0.139 – KWD 0.141
200 M 1
FY2027 KWD 0.093
KWD 0.044 – KWD 0.142
210 M 2

النقاط الرئيسية

Revenue grew 31.55% annually over 5 years — strong growth
Earnings declined -123.00% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Generating 151,611.0 in free cash flow
PEG of 0.88 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 32.85%

النمو

Revenue Growth (5Y)
31.55%
Revenue (1Y)64.40%
Earnings (1Y)-123.00%
FCF Growth (3Y)N/A

الجودة

Return on Equity
-0.88%
ROIC-0.20%
Net Margin-4.89%
Op. Margin-1.51%

الأمان

Debt / Equity
0.00
Current Ratio19.59
Interest Coverage0.00

التقييم

P/E Ratio
-105.04
P/B Ratio0.91
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 64.40% Revenue Growth (3Y) 48.88%
Earnings Growth (1Y) -123.00% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 31.55% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 193.36M Net Income (TTM) -9.45M
ROE -0.88% ROA -0.79%
Gross Margin 32.46% Operating Margin -1.51%
Net Margin -4.89% Free Cash Flow (TTM) 151,611.0
ROIC -0.20% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 19.59
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -105.04 P/B Ratio 0.91
P/S Ratio 5.13 PEG Ratio 0.88
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 992.32M Enterprise Value 202.03M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 193.36M 117.62M 87.24M 86.75M 64.56M
Net Income -9.45M 41.08M -73.96M -168.73M -396.11M
EPS (Diluted) -0.02 0.11 -0.19 -0.45 -1.07
Gross Profit 62.76M 25.20M 11.91M 15.44M -17.59M
Operating Income -2.93M -76.53M -84.80M -111.43M -291.97M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.20B 1.17B 1.14B 1.21B 1.40B
Total Liabilities 54.18M 55.33M 44.14M 72.05M 63.46M
Shareholders' Equity 1.09B 1.06B 1.10B 1.14B 1.34B
Total Debt 1.51M 2.02M 2.55M 3.88M 9.81M
Cash & Equivalents 791.79M 858.81M 669.29M 764.64M 886.97M
Current Assets 944.09M 936.11M 933.31M 960.16M 1.08B
Current Liabilities 48.19M 49.70M 41.40M 68.12M 54.37M

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#14 of 146
69

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل Full Throttle
Mar 24, 2026